New Lymphoma Drug, Thanks to Hadassah and Pennsylvania Physician/Scientists
KAHR-102, a new immunotherapy drug to treat lymphoma, based on technology developed by Hadassah Medical Center Nephrologist Prof. Michal Dranitzki Elhalel and Pennsylvania Pathologist Prof. Mark L. Tykocinski, will begin…
